Life has a way of leaving marks. A scraped knee. A quiet ache. A moment that stops you in your tracks.
But every wound, no matter how small, is a sign that you’ve moved, that you’ve lived, that you’ve dared. And it deserves to be cared for—with intention, with science, and with heart.
That’s where Bonvadis begins.
Inspired by the Greek word “vadízo̱”— meaning “Where are you going?”—Bonvadis is more than a name. It’s a promise: That no matter where you are today, there is always a better direction. A better path. A better you.
As a trusted leader in advanced wound care, Bonvadis combines nature’s healing wisdom with modern clinical expertise to create herbal-based healing cream that do more than just treat the skin. They support resilience. They restore confidence. They help you move forward—one step, one breath, one day at a time. Because true healing isn’t just physical. It’s emotional. It’s empowering. It’s a quiet strength.
Keep walking. Keep going.
Even if the steps are small, even if the road feels long.
Bonvadis is here—to heal, to protect, to walk with you.
Healing that moves with you. One wound at a time. One future at a time.
As a trusted leader in advanced wound care, Bonvadis combines nature’s healing wisdom with modern clinical expertise to create herbal-based healing cream that do more than just treat the skin. They support resilience. They restore confidence. They help you move forward—one step, one breath, one day at a time. Because true healing isn’t just physical. It’s emotional. It’s empowering. It’s a quiet strength.
Keep walking. Keep going.
Even if the steps are small, even if the road feels long.
Bonvadis is here—to heal, to protect, to walk with you.
Healing that moves with you. One wound at a time. One future at a time.
Founded in 2008 in Taipei, Taiwan, Oneness Biotech (TPEx: 4743) is a leading biotechnology company, dedicated to the development of innovative products for metabolic disorders. The company has been public-listed on Taipei stock exchange since 2011 and become a commercial-stage biotech for global commercialization in 2025.
Founded in 2008 in Taipei, Taiwan, Oneness Biotech (TPEx: 4743) is a leading biotechnology company, dedicated to the development of innovative products for metabolic disorders. The company has been public-listed on Taipei stock exchange since 2011 and become a commercial-stage biotech for global commercialization in 2025.
Oneness continues to conduct non-clinical and clinical trials for the global unmet medical need in compliance with the international regulations. This ensures the effectiveness, safety and consistency of the drugs, develops drugs, and medical devices with the advantages in market competitiveness. Our business philosophy is to meet the medical needs of patients and create business value. We drive the innovative products into the global market by establishing global collaboration and alliance in order to facilitate the global market access and maximize benefits for patients.
Oneness continues to conduct non-clinical and clinical trials for the global unmet medical need in compliance with the international regulations. This ensures the effectiveness, safety and consistency of the drugs, develops drugs, and medical devices with the advantages in market competitiveness. Our business philosophy is to meet the medical needs of patients and create business value. We drive the innovative products into the global market by establishing global collaboration and alliance in order to facilitate the global market access and maximize benefits for patients.
Date of Publication: August 2024
Period: Jan. 01, 2023 to Dec. 31, 2023
Thank you for reading the ESG Report issued by Oneness Biotech Co., Ltd. (hereinafter referred to as Oneness Biotech). By taking the initiative of issuing the ESG report, Oneness Biotech hopes to explain to the employees, customers, investors, and other stakeholders the efforts it has devoted to and the results it has achieved in terms of ethical management, new drug R&D, business performance, employee welfare, environment protection, and many other aspects under the goal of corporate sustainability. We hope that the stakeholders can continue to follow us and provide us with valuable advice so that we can continue to proceed steadily on the path of corporate sustainability.
(Date of next publication: August 2025)
Included in S&P Global’s “2023 Sustainability Yearbook” and awarded the “Best Progress Award” in international sustainability assessments.
The Asian Business Association’s “International Innovation Award”
13th National Innovation Award, Corporate Innovation Award in the Biopharmaceutical and New Medical Technology Category
National Biotech Medical Quality Bronze Award (Nutritional Health Food Category, Health Food Group)
National Quality Mark Certificate
The manufacturing site is located in Nanchou Township, Pingtung County, and has been established on the basis of the sustainable, environmentally-friendly core value. The plant has been ISO 14001 certified in 2021, and ISO 14044, 14040 and 14067 verified in 2022.
The manufacturing site is located in Nanchou Township, Pingtung County, and has been established on the basis of the sustainable, environmentally-friendly core value. The plant has been ISO 14001 certified in 2021, and ISO 14044, 14040 and 14067 verified in 2022.
